(95 days)
No
The document describes a physical implant (spacer) made of PEEK with Tantalum wires for visualization. There is no mention of software, algorithms, or any computational processing that would suggest the use of AI or ML. The performance studies focus on mechanical testing and design verification of the physical device.
Yes.
The device is used for intervertebral body fusion of the spine for the treatment of degenerative disease, aiming to alleviate pain and facilitate fusion, which is a therapeutic purpose.
No
This device is a surgical implant designed for intervertebral body fusion, used to stabilize the spine after disc removal. It is a treatment device, not a diagnostic one.
No
The device description explicitly states it is a "spacer" manufactured from PEEK and containing Tantalum wires, which are physical components, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Reliance Lumbar IBF System Function: The description clearly states that the Reliance Lumbar IBF System is a surgically implanted device used for intervertebral body fusion in the spine. It is a physical spacer made of PEEK and Tantalum, designed to be placed between vertebrae.
- Lack of Diagnostic Testing: The device does not perform any tests on bodily samples to diagnose or monitor a condition. Its purpose is structural support and to facilitate bone fusion.
The information provided describes a surgical implant, not a diagnostic test performed outside the body.
N/A
Intended Use / Indications for Use
The Reliance Lumbar IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level.
The Reliance Lumbar IBF System, when used as an Intervertebral Body Fusion device is also intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disease (DDD) with up to Grade 1 Spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is to be used with patients who have had six months of non-operative treatment.
Product codes
MAX
Device Description
The Reliance Lumbar IBF System, originally cleared by FDA in K113540, is intended to be used as an intervertebral body fusion device. Reliance Lumbar IBF device is a spacer, which inserts between vertebral bodies in the anterior column of the thoracic and lumbar spine. The device is surgically implanted between vertebral bodies from an anterior, lateral, or posterior surgical approach. The Reliance Lumbar IBF device will be manufactured from PEEK. The PEEK device also contains Tantalum wires to aid in fluoroscopic visualization. The construct is not intended to be employed as a standalone device. The Reliance Lumbar IBF is to be used with supplemental fixation in all applications.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
lumbar spine, from L2 to S1
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Based on risk analysis for the new implant sizes and design verification testing conducted on the Reliance Lumbar IBF System instruments, it was determined that the inclusion of these implants and instruments into the Reliance Lumbar IBF System does not create a new worst-case test condition for mechanical testing, performance testing, sterilization, biocompatibility, cleaning or packaging. Therefore, in accordance with the design control process, additional performance data was not necessary for the changes subject of this Special 510(k).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services USA and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, featuring a stylized eagle emblem encircled by the department's name. To the right is the FDA logo, with the acronym "FDA" in a blue square, followed by "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
January 19, 2018 Reliance Medical Systems, LLC Bret Berry Owner 545 West 500 South Suite 100 Bountiful, Utah 84010
Re: K173283
Trade/Device Name: Reliance Lumbar IBF System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral Body Fusion Device Regulatory Class: Class II Product Code: MAX Dated: December 18, 2017 Received: December 26, 2017
Dear Bret Berry:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Vincent J. Devlin -S
for
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K173283
Device Name Reliance Lumbar IBF System
Indications for Use (Describe)
The Reliance Lumbar IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level.
The Reliance Lumbar IBF System, when used as an Intervertebral Body Fusion device is also intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disease (DDD) with up to Grade 1 Spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is to be used with patients who have had six months of non-operative treatment.
| Type of Use (Select one or both , as applicable) |
|---|
| ---------------------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Section 6: 510(k) Summary
Reliance Medical Systems, LLC 545 West 500 South Suite 100 Bountiful, UT 84010 Telephone: (801) 295-3280 Fax: (801) 294-0079
October 13, 2017
Contact: Bret M. Berry, Member-Manager
Common or Usual Name: Intervertebral Body Fusion Device Proposed Proprietary or Trade Name: Reliance Lumbar IBF System Classification Name: Intervertebral Body Fusion Device Regulation Number: 21 CFR 888.3080 Product Code: MAX
Substantial Equivalence:
The subject Reliance Lumbar IBF System is substantially equivalent to the legally marketed primary predicate device, the Reliance Lumbar IBF System (K160463). The subject Reliance Lumbar IBF System is equivalent to its predicate in terms of intended use, indications for use, design, function, principle of operation, materials, levels of attachment, and use with supplemental fixation.
Device Description:
The Reliance Lumbar IBF System, originally cleared by FDA in K113540, is intended to be used as an intervertebral body fusion device. Reliance Lumbar IBF device is a spacer, which inserts between vertebral bodies in the anterior column of the thoracic and lumbar spine. The device is surgically implanted between vertebral bodies from an anterior, lateral, or posterior surgical approach. The Reliance Lumbar IBF device will be manufactured from PEEK. The PEEK device also contains Tantalum wires to aid in fluoroscopic visualization. The construct is not intended to be employed as a standalone device. The Reliance Lumbar IBF is to be used with supplemental fixation in all applications.
Intended Use / Indications for Use:
The Reliance Lumbar IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level.
4
The Reliance Lumbar IBF System, when used as an Intervertebral Body Fusion device is also intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1. for the treatment of degenerative disc disease (DDD) with up to Grade 1 Spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is to be used in patients who have had six months of non-operative treatment.
Technological Modifications:
The subject Reliance Lumbar IBF system offers additional implant and instrument components. These include additional implant sizes for use in the Lumbar IBF System, specifically the 10x22. 30x26, 34x27, 45x18, 50x18, 55x18, 55x22, and 60x26mm implant sizes. Additional instruments submitted here as accessories to the Reliance Lumbar IBF System are the Reliance Lumbar Graft Impactor and the Reliance Lumbar Graft Block and Double Graft Block. Finally, the 45x18, 50x18. 55x18. 60x18. 45x22. 50x22. 60x22. 60x24. and 60x26mm implant sizes have been made stronger by increasing the teeth depth on the superior and inferior surfaces.
There have been no changes to intended use, indications for use, function, principle of operation, materials, levels of attachment, method of insertion, or labeling.
Performance Data and Substantial Equivalence:
Based on risk analysis for the new implant sizes and design verification testing conducted on the Reliance Lumbar IBF System instruments, it was determined that the inclusion of these implants and instruments into the Reliance Lumbar IBF System does not create a new worst-case test condition for mechanical testing, performance testing, sterilization, biocompatibility, cleaning or packaging. Therefore, in accordance with the design control process, additional performance data was not necessary for the changes subject of this Special 510(k).
Conclusion
The Reliance Lumbar IBF System is substantially equivalent to the identified predicate device.